Anatomy Other topics and Adverse effects 5d77a71b An agent that activates natural killer cells and is useful in renal cell carcinoma is A Aldesleukin B Etanercept C Leflunomide D Thalidomide High-Yield Explanation Ref-Katzung 10/e p816 Recombinant IL-2 is used for the treatment of maligant melanoma and renal cell carcinoma